Acute Oroantral Communication Closure: Resorbable Collagen Membrane vs. Buccal Advancement Flap Outcomes: A Clinical Trial
Journal of Functional Biomaterials · 18.03.2026 · 17 (3) · 150
DOI: 10.3390/jfb17030150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Biomaterials, online erschienen am 18.03.2026. Verfasst von Agnieszka Balicz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dental Surgery, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Oroantral communication (OAC) is a frequent complication after the extraction of maxillary posterior teeth and requires immediate closure to prevent sinus pathology and long-term functional impairment.
Objectives
This study aimed to compare the clinical and radiographic outcomes of acute OAC closure using resorbable heterogeneous collagen membranes with those of the conventional buccal advancement flap (Rehrmann method).
Methods
Twenty-four patients with OACs diagnosed within 24 h post-extraction were enrolled, and 20 completed follow-up. Patients were allocated to a membrane group treated with a resorbable collagen membrane (Creos Xenoprotect) or a control group treated with a buccal advancement flap. Clinical parameters, including vestibular depth, width of keratinized gingiva, alveolar socket dimensions, postoperative complications, and pain intensity assessed using the Visual Analogue Scale, were evaluated at 1, 7, 14, and 90 days. Radiographic outcomes were assessed using cone-beam computed tomography with linear measurements and normalized bone density analysis in Hounsfield Units at baseline and 90 days.
Results
The membrane technique provided significantly better preservation of vestibular depth, keratinized gingiva width, and alveolar socket dimensions, with significantly lower postoperative pain and fewer complications compared with the buccal advancement flap. Higher normalized bone density values were observed in the membrane group, although differences were not statistically significant.
Conclusions
Resorbable collagen membranes represent a safe, minimally invasive, and clinically effective alternative to buccal advancement flaps for acute OAC closure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dental Surgery, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
- Faculty of Science and Technology, University of Silesia, 40-007 Katowice, Poland.
- Department of Dentistry, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava-Jih, Czech Republic.
- Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
ORCID-Profile: Agnieszka Balicz, Agnieszka Szurko, Agnieszka Kiełboń, Martin Starosta
Zitieren
APA
Balicz, A., Szurko, A., Jędzierowska, M., Kiełboń, A., Wójcik, S., Adamczyk, J., Starosta, M., Fiegler-Rudol, J., & Morawiec, T. (2026). Acute Oroantral Communication Closure: Resorbable Collagen Membrane vs. Buccal Advancement Flap Outcomes: A Clinical Trial. Journal of Functional Biomaterials, 17(3), 150. https://doi.org/10.3390/jfb17030150
Vancouver
Balicz A, Szurko A, Jędzierowska M, Kiełboń A, Wójcik S, Adamczyk J, et al. Acute Oroantral Communication Closure: Resorbable Collagen Membrane vs. Buccal Advancement Flap Outcomes: A Clinical Trial. Journal of Functional Biomaterials. 2026;17(3):150. doi:10.3390/jfb17030150
BibTeX
@article{Balicz2026,
author = {Balicz, Agnieszka and Szurko, Agnieszka and Jędzierowska, Magdalena and Kiełboń, Agnieszka and Wójcik, Sylwia and Adamczyk, Jakub and Starosta, Martin and Fiegler-Rudol, Jakub and Morawiec, Tadeusz},
title = {Acute Oroantral Communication Closure: Resorbable Collagen Membrane vs. Buccal Advancement Flap Outcomes: A Clinical Trial},
journal = {Journal of Functional Biomaterials},
year = {2026},
volume = {17},
number = {3},
pages = {150},
doi = {10.3390/jfb17030150}
}
EUVIMED